Skip to main content
CG Invites Co., Ltd. logo

CG Invites Co., Ltd. — Investor Relations & Filings

Ticker · 083790 ISIN · KR7083790006 KO Manufacturing
Open in API
Filings indexed 450 across all filing types
Latest filing 2024-11-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 083790

About CG Invites Co., Ltd.

https://cginvites.com/en

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.

Recent filings

Filing Released Lang Actions
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for CG Invites Co., Ltd. for the period ending September 30, 2024. It contains detailed financial information, business operations, management discussion, and corporate governance data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-13 Korean
[기재정정]분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '크리스탈지노믹스(주)' (now CG인바이츠(주)). It contains detailed financial data, business operations, and management discussions for the period of 2024.01.01 to 2024.03.31. It is a formal regulatory filing submitted to the Financial Services Commission and Korea Exchange. Based on the content, it is a comprehensive interim/quarterly financial report. Q1 2024
2024-11-12 Korean
[기재정정]타법인주식및출자증권처분결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from CG Invites regarding the 'Decision to Dispose of Shares and Equity Securities of Other Corporations' (타법인주식및출자증권처분결정). It is a correction filing (정정신고) for a previous disclosure made on 2024-11-04. Since this document details a specific corporate transaction (disposal of shares in another company) and does not fit into specific categories like M&A (which usually implies a merger or takeover bid) or Share Issue/Capital Change, it is best classified as a general Regulatory Filing (RNS) under the provided schema.
2024-11-05 Korean
타법인주식및출자증권처분결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from CG Invites regarding the 'Decision to Dispose of Shares and Equity Securities of Another Corporation' (타법인주식및출자증권처분결정). This is a specific corporate action announcement detailing the sale of shares in another company (Pangen) to improve liquidity and financial structure. Since it does not fit into specific categories like M&A (which usually implies a merger or acquisition of the company itself) or share buybacks (which is 'Transaction in Own Shares'), and it is a formal regulatory disclosure of a corporate transaction, it falls under the general regulatory filing category.
2024-11-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the acquisition of shares by a major shareholder (Invites Biocore) in the issuing company (CG Invites). This type of filing is specifically categorized as a Director's Dealing (DIRS) report, as it tracks insider/major shareholder transactions in the company's own securities.
2024-11-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in share ownership by major shareholders or insiders, which corresponds to the 'Director's Dealing' (DIRS) category in the provided schema.
2024-10-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.